.

Previous Requests - November 2017

Date     Reference Question(s) Response 
01/11/2017 721/17 

1. For each of the listed licensed Somatropin preparations please provide information on restrictions:

a. Are there any restrictions to the prescribing of each preparation? IF YES - Please state, where possible, the reason for the restriction and if the restriction applies to children (patients aged 18 or under)
b. Are there any planned changes to these restrictions over the period of the rest of this financial year (2017/18) and 2018/19? IF YES - please provide details of planned changes. 

2. Please provide a copy of the latest written policy, protocol, pathways, shared care agreement or other literature outlining your organisation’s recommendations for the use of licensed Somatropin preparations in children (patients aged 18 or under) in line with NICE TA 188? If the information is already in the public domain could you please provide the direct URL to where this information is located?

3. Are local policies for the use or restriction of licensed Somatropin preparations in patients aged 18 or under led by specialists in hospital or medicines optimisation/medicines management pharmacists within your organisation?

4. Does your organisation monitor adherence or have internal audits in place to monitor adherence in patients who have been prescribed a Somatropin product? IF YES please provide details.

Click here for Response
01/11/2017 722/17

1. Number of haemangioma diagnoses within your commissioning group area for the last 5 year period, split by age group of patient.

2. How many of these diagnoses were actually located on the patients face or classified as on their facial area?

3. Of those numbers from request ‘2’; diagnosis on the facial area, could you please confirm how many were or are due to be surgically removed?

4. Of those numbers from request ‘2’; could you please confirm how many were classified as on a ‘sensitive area’?

5. Of those from request ‘4’, how many were or are due to be surgically removed?

Click here for Response
01/11/2017 723/17

1. Provide a copy of the CCGs hernia commissioning guidance.

2. Provide a list of names of those who contributed to the guidance, and their email addresses.

3. Who is the lead clinical advisor for hernia (if application) at your CCG? What is their email address?

Click here for Response

Click here for Attachment

06/11/2017 725/17

I would like to ask if you could provide an email of a person who is involved in respiratory care commissioning in primary care and/or a clinical lead for asthma and COPD.

Click here for Response
06/11/2017  726/17

Please provide me figures under the Freedom of Information Act of how much each CCG is paying to GP At Hand 2017 to provide this service - https://www.gpathand.nhs.uk/our-nhs-service.

Click here for Response
07/11/2017 727/17

1. Do you have a formulary used by primary care prescribers?  If so, what is the current status of nitrofurantoin and trimethoprim with respect to urinary tract infections (Eg. first line, second line, etc.)?

2. Has the status of either nitrofurantoin or trimethoprim changed in the formulary since November 2014?  If so, please provide the previous status(es) and details of the date(s) of change.

3. Have you had any work plans in place with respect to nitrofurantoin and trimethoprim prescribing since 2014?  If so, please provide documents and start date.

4. Have you had any GP prescribing incentive schemes or similar which relate to trimethoprim or nitrofurantoin prescribing since November 2014?  If so, please provide the documents.

Click here for Response
08/11/2017 728/17

1. Regarding the CCG:
a. Are adult hearing services currently being delivered through Any Qualified Provider (AQP) within the CCG?
b. Does the CCG use AQP for any other services provided? If so, what services?  

2. Regarding the CCG IF currently using AQP in the audiology service (IF NOT, please move to part 3). The audiology services provided by AQP:
a. When did the CCG begin using AQP?
b. Who are the current providers for audiology services?
c. How many AQP providers does the CCG have?
d. What percentage of provision is provided by private sector companies and NHS services within the CCG?  

Type of AQP service provided:
d. Are they a Consultant led service?
e. What are the current appointment waiting times for the Audiology service?
f. What percentage of patients are fitted with bilateral hearing aids?
g. Are the type of hearing aid that providers fit audited? If so, what make and model of Hearing Aids are used?
h. Does the AQP service provide balance/diagnostic services?
i. Does the AQP service offer appointments for repairs or open clinics? 

Referral to the audiology service:
j. Is a ‘Choose and Book’ system used for audiology referrals?
k. Can patients be directly referred to an AQP audiology service by their GP?
l. From what age of patient do they accept Direct Referrals?
m. What percentage of referrals are a direct referral to an AQP audiology service?  

Cost of the service:
n. What is the current contract value of the Audiology service provided by AQP?
o. Is the Audiology service being operated within the current contract value?
p. What is the current contract length for the Audiology service?
q. When is the current contract due to expire?
r. Does the CCG have plans to continue using AQP for the audiology service after the current contract ends?  

3. Regarding the CCG IF NOT currently using AQP in audiology:
a. Has the CCG used AQP to provide audiology services before?
b. When did the CCG stop using AQP in audiology?

Click here for Response
10/11/2017 729/17

1. How many cycles of IVF has the authority funded in each of the financial years:
a. 2014/15
b. 2015/16
c. 2016/17 

2. What was the total amount paid by the authority in each of these years to providers in payment for IVF services?
a. 2014/15
b. 2015/16
c. 2016/17 

3. How many of the cycles stated in each year in answer to question 1 above were provided by NHS providers, and how many were provided by private or third sector providers?
a. 2014/15
b. 2015/16
c. 2016/17 

4. Are individuals for whom the authority funds IVF services given any choice of provider? For example, does the authority procure a list of qualified providers and allow individuals eligible for IVF to choose from this list, or does the authority require individuals to use a provider nominated by the authority?

5. How, if at all have the authorities funding criteria for IVF services changed between the financial year 2014/15 and 01/11/2017. For example:
a. Has the number of cycles funded changed (if so, from what to what?)
b. Has the minimum age changed (if so, from what to what?)
c. Has the maximum age changed (if so, from what to what?)
d. Has the time trying to conceive criteria changed (if so, from what to what?)
e. Have criteria relating to previous children changed (if so, from what to what)
f. Have any other criteria changed or been introduced in this period, eg BMI

Click here for Response
10/11/2017 730/17

1. Does your CCG have a policy on the use of health apps?

2. If yes, please provide the policy (or policies) and contact details.

3. Do you currently have specific budgets for the use of health apps within your CCG?

4. If yes, please provide a contact for any budgets related to the use of health apps.

5. Are there individual health apps specified for patient use? Please provide a list of these.

6. If yes, please specify which of these health apps is paid for by the CCG.

7. Please specify who is responsible for the funding of each app that is paid for by the CCG and provide contact details?

Click here for Response
13/11/2017 731/17

1. Does your Trust/CCT currently use a private company to undertake any of the following services?

  • Public Relations
  • Social Media Communications
  • External Stakeholder Communications
  • Internal Stakeholder Communications

2. If yes, can you please confirm:
a. When the current contract(s) was/were last let
b. When the current contract(s) expires/expire
c. Whether the current contract(s) has/have options to extend its length
d. When you expect to retender the contract(s) 

3. If no (to question 1 above), are you considering letting such a contract(s) in the future and if so, do you have an approximate timetable for engaging the market? 

4. Have you used a private company to help you with any other marketing or public information campaigns in the past 2 years?

5. If so, could you please provide a brief overview of what those campaigns were about and approximately how long your contract with the company was for to support the campaign(s)?

Click here for Response
13/11/2017 732/17

1. Given the new NICE guidelines, does the Southern Derbyshire CCG have an interim position policy? (Many CCGs in the UK have released one following NICE’s announcement – does South Derbyshire CCG intend to issue one?)

2. What is the unit cost for Accu-chek Mobile Testing cassettes? (my current prescription)

3. In my case, the Freestyle libre will be almost 46% cheaper, and I can also demonstrate that it has also significantly improved my HBA1c – what other criteria do I need to demonstrate in order to get this prescribed in South Derbyshire CCG?

Click here for Response
13/11/2017 733/17 We are interested in paediatric audiology services commissioned by CCGs across England. Click here for Response
15/11/2017 734/17

1.    Have referral policies changed for elective procedures for patients who are obese (with a BMI of 30 or above)?   

2.    Have referral policies changed for elective procedures for patients who smoke?  

3.    Are you considering changing referral policies for elective procedures for patients who are obese?   

4.    Are you considering changing referral policies for elective procedures for patients who smoke?   

5.    If yes to any of the above what has the change been or what change are you considering?   

6.    What is the current average wait from referral to treatment for elective hip replacements for patients who are obese or smoke?  

7.    What is the current average wait from referral to treatment for elective hip replacements for patients who are not obese and do not smoke?

Click here for Response
15/11/2017 735/17

1. Who provides your current Wheelchair Service

a. Is your provider an NHS organisation or a contracted-out, non-NHS organisation?

b. What is the name of your current provider?

c. What is the name of the Wheelchair Service Manager? 

2. How your wheelchair services are provided

a. Do you combine your Wheelchair Service with any other service, such as Prosthetics or Community Equipment? If so, please provide a list of the other services.

b. Is your Wheelchair Service exclusive to your CCG?

c. If you service is combined with another please provide a list of the CCGs that share this Wheelchair Service and confirm who is the lead CCG?

d. Is the Repair and Maintenance element of the service “integrated” or contracted out to a 3rd party Approved Repairer?

e. If you have an externally provided Approved Repairer, what is the name of your current provider? 

3. About your wheelchair service

a. What is the size of the population covered by your Wheelchair Service?

b. How many registered service users are served by the Wheelchair Service? 

4. About the Integrated (Combined service and Repair & Maintenance) contract with your provider

a. What is the contract spend in the last financial year for the Integrated Wheelchair Service?

b. Please state the dates of your last financial year. 

c. When was the Integrated Wheelchair Service last tendered?

d. When does the current contract expire please provide details of any potential contract extension?

e. Please provide the date this Wheelchair Service will be next tendered 

5. About the Repair and Maintenance (R&M) sub-contract with your wheelchair provider (where appropriate)

a. What is the contract spend in the last financial year for the R&M Wheelchair Service?

b. Please state the dates of your last financial year.

c. When was the R&M Wheelchair Service last tendered?

d. When does the current R&M sub-contract expire please provide details of any potential contract extension

e. Please provide the date that R&M Wheelchair Service sub-contract will be next tendered

Click here for response
16/11/2017  736/17 How many patients have been referred by their GP for elective care but have been unable to receive treatment because of a) being a smoker, and b) having a BMI over 30 for each of the following periods:
  • 2014/15;
  • 2015/16;
  • 2016/17;
  • and the first two quarters of 2017/18. 

Please ensure you provide answers for a) and b) in each period separately, where possible. Many thanks indeed for your assistance on this.

Click here for Response
 16/11/2017 737/17  
  1. What was your total CCG 2015/16 outturn?
  2. What was your total CCG 2016/17 outturn?
  3. What was your planned spend as a proportion of overall CCG allocation in 2015/16 on mental health?
  4. What was your planned spend as a proportion of overall CCG allocation in 2016/17 on mental health?
  5. What was your total planned spending for mental health 2016/17?
  6. What was your total planned spending for mental health 2015/16?
  7. What was your mental health 2015/16 outturn?
  8. What was your mental health 2016/17 outturn?

Click here for Response

Click here for Attachment

19/11/2017 738/17

A list of all GP Federations (alliance, network, social enterprise, collaboration or any other associative name) etc. that operate through Southern Derbyshire CCG. 

The list will include:

  • Name of the Federation
  • Number and list of names of practices
  • Structure of each Federation (whether a LTD company, LLP, coop, CIC etc.)
  • Main point of contact for each Federation
  • Population covered
Click here for Response
20/11/2017 739/17

1.    How much money was spent in total on the management of diabetic wounds (A: clinician hourly rates, B: cost of materials) effecting the sole of the foot between January 2015 and January 2017?

2.    How much money was spent on offloading orthoses (insoles that reduce high pressure points of the foot) for patients with diabetes between January 2015 and January 2017? 

3.     How much money was spent on TTCs (Total Contact Casts) used in the management of foot wounds in diabetic patients between January 2015 and January 2017?

4.     How much money was spent on bespoke footwear (customised shoes) made for patients with diabetes-related foot complications between January 2015 and January 2017?

5.  How many home visits were there related to the care for patients with diabetic neuropathic ulcers in 2015-2017 by:
a)    District nurses; and
b)    Podiatrists?

6.   What is the total cost of routine podiatry appointments for patients with diabetic neuropathic ulcers?

Click here for Response
20/11/2017 740/17

1. How many patients within your CCG were deemed eligible for NHS Continuing Healthcare packages in the financial years 2016/17, 2015/16 and 2014/15? Please could I have this information broken down by year? 

2. How many patients within your CCG died in hospital while awaiting the start of a NHS Continuing Healthcare care and support package in the financial years 2016/17, 2015/16 and 2014/15? Please could I have this information broken down by year? 

3. How many patients in the last four financial years have waited more than a) one week b) one month c) one year to receive a care and support package after being found eligible for NHS Continuing Healthcare? Please could I have this information broken down by year? 

4. What was the longest wait between a patient being found eligible for NHS Continuing Healthcare and receiving a care and support package in the financial years 2016/17, 2015/16 and 2014/15? Please could I have this information broken down by year?

Click here for Response
22/11/2017 741/17

In relation to the Freedom of Information Act please can you reply with structure charts with a full breakdown of every department within the Finance Department with all recruiting managers.

Click here for Response

Click here for Attachment

22/11/2017 742/17

1.     Which company(s) holds the contract to supply your current patient transport services.

2.     Please state the full name of your CCG

3.     Please state if this service was procured through a framework agreement with other CCGs / NHS Trusts (if so please provide the names of the other CCG’s / NHS Trusts). If yes, please also state which CCG holds the contract.

4.     Please state the contract start date and end date of your current transport services.

5.     What is the expected total value of the contract?

6.     What is your annual budget for patient transport services?

7.     Are there provisions for contract extensions (including how many years and the extension terms). If yes, please state if the contract extension been awarded

8.     Please state the names of the organisations who bid for the contract

9.     How many patients are transported annually by your patient transport providers, and how many journeys are undertaken?

10.  What would the procurement model be for future contracts? E.g. will the contract be procured jointly with another CCG?

11.  What are the performance standards the current service provider(s) operate under? (e.g. Discharge - 90% of patients to be collected in 4 hours of ready time. Categories for performance usually being Discharge from inpatient, Travel Time, Arrival time & Departure time)

12.  What is the current provider’s performance against these standards in the last 12 months? (e.g. Discharge – 70% of have patients have been collected in 4 hours of ready time)

Click here for Response

Click here for Attachment 1

Click here for Attachment 2

23/11/2017 743/17

1. If your organisation is a commissioner of services which are usually designated as IAPT (Improving Access to Psychological Therapies) Services, ‘primary care’ and ‘Step 2/3’ services, please send the following information for these services:

Are these services commissioned or not commissioned by your organisation?

Please provide information on the total cost of this service for the period 1 April 2016 to 31 March 2017.

If this service is commissioned by you in collaborative or joint arrangements with other Clinical Commissioning Groups please provide their names.

Please give the names of providers of these services commissioned by you.

For each of the following psychological therapies/treatments:

CAT (Cognitive Analytic Therapy)
CBT (Cognitive Behavioural Therapy)
CS (Counselling)
CT (Cognitive Therapy)
DBT (Dialectical Behaviour Therapy)
DIT (Dynamic Interpersonal Therapy)
EFT (Emotion Focused Therapy)
IPT (Interpersonal Therapy)
LTPP (Long Term Psychodynamic Psychotherapy) (An explicit expectation of open ended treatments in excess of 1 year)
MBT (Mentalization Based Therapy)
ST (Systemic Therapy)
STPP (Short Term Psychodynamic Psychotherapy) (An explicit expectation of short treatments in less than 16 sessions)
TFP (Transference Focused Psychotherapy)

Please provide the following information:

Please give the number of staff delivering the psychological therapy/treatment in whole time equivalents (WTEs). If none please state ‘none’. If not known please state ‘not known’.

For each of the years 1 April 2014 to 31 March 2015, 1 April 2015 to 31 March 2016, and 1 April 2016 to 31 March 2017 please provide the number of completed treatments/episodes for each psychological therapy/treatment. If none please state ‘none’. If not known please state ‘not known’.

Please list the names of outcome measures used with each psychological therapy/treatment, prioritised with your considered most important measure first, and to a maximum of three measures. If none please state ‘none’.

Please provide the ‘mean start score’ and mean end score’ for each of the outcome measures you have listed, used with each psychological therapy/treatment, for each of the years 1 April 2014 to 31 March 2015, 1 April 2015 to 31 March 2016, and 1 April 2016 to 31 March 2017. Where, as standard, ‘start’ is the first recorded measure at the beginning of therapy/treatment and ‘end’ is the last recorded measure at the end or therapy/treatment. If none please state ‘none’. If not known please state ‘not known’. 

2. If your organisation is a commissioner of services which are usually designated as Secondary Mental Health Services, ‘secondary/tertiary care’ and ‘Step 4/5’ services, please send the following information for these services:

Are these services commissioned or not commissioned by your organisation?

Please provide information on the total cost of this service for the period 1 April 2016 to 31 March 2017.

If this service is commissioned by you in collaborative or joint arrangements with other Clinical Commissioning Groups please provide their names.

Please give the names of providers of these services commissioned by you.

For each of the following psychological therapies/treatments:

CAT (Cognitive Analytic Therapy)
CBT (Cognitive Behavioural Therapy)
CS (Counselling)
CT (Cognitive Therapy)
DBT (Dialectical Behaviour Therapy)
DIT (Dynamic Interpersonal Therapy)
EFT (Emotion Focused Therapy)
IPT (Interpersonal Therapy)
LTPP (Long Term Psychodynamic Psychotherapy) (An explicit expectation of open ended treatments in excess of 1 year)
MBT (Mentalization Based Therapy)
ST (Systemic Therapy)
STPP (Short Term Psychodynamic Psychotherapy) (An explicit expectation of short treatments in less than 40 sessions)
TFP (Transference Focused Psychotherapy) 

Please provide the following information:

Please give the number of staff delivering the psychological therapy/treatment in whole time equivalents (WTEs). If none please state ‘none’. If not known please state ‘not known’.

For each of the years 1 April 2014 to 31 March 2015, 1 April 2015 to 31 March 2016, and 1 April 2016 to 31 March 2017 please provide the number of completed treatments/episodes for each psychological therapy/treatment. If none please state ‘none’. If not known please state ‘not known’.

Please list the names of outcome measures used with each psychological therapy/treatment, prioritised with your considered most important measure first, and to a maximum of three measures. If none please state ‘none’.

Please provide the ‘mean start score’ and mean end score’ for each of the outcome measures you have listed, used with each psychological therapy/treatment, for each of the years 1 April 2014 to 31 March 2015, 1 April 2015 to 31 March 2016, and 1 April 2016 to 31 March 2017. Where, as standard, ‘start’ is the first recorded measure at the beginning of therapy/treatment and ‘end’ is the last recorded measure at the end or therapy/treatment. If none please state ‘none’. If not known please state ‘not known’.

Click here for response
23/11/2017 744/17

1. Do you hold the budget for Mental Health Transport or is it held by the Trusts in your area? 

2. Who currently provides your NEPTS (Non-Emergency Patient Transport Services)? 

3. When is your NEPTS contract up for renewal? 

4. Are your mental health services commissioned within a wider Patient Transport Service? 

5. Do you make use of providers other than your main contracts for Adhoc journeys or repatriations? 

6. Do you use caged vehicles for your mental health journeys? 

7. Do you commission a courier services and if so when does the contract expire?

Click here for Response
28/11/2017 745/17

1. Does Southern Derbyshire CCG currently have a guideline in place for the use of Ursodeoxycholic acid 250mg TABLETS? 

2. If the answer is ‘yes’ to request 1, could you send me details of this guideline.

Click here for Response
Last modified: 15/12/2017